BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25297738)

  • 1. [Recent progress in the management of aplastic anemia].
    Nakao S
    Rinsho Ketsueki; 2014 Oct; 55(10):1762-8. PubMed ID: 25297738
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent issues and prospects of the treatment of aplastic anemia].
    Nakao S
    Rinsho Ketsueki; 2014 Jan; 55(1):5-11. PubMed ID: 24492031
    [No Abstract]   [Full Text] [Related]  

  • 3. Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia.
    Cheng H; Wang X; Zhou D; Cao J; Larochelle A; Xu KL
    Ann Hematol; 2019 Aug; 98(8):2009-2011. PubMed ID: 30891613
    [No Abstract]   [Full Text] [Related]  

  • 4. Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag.
    Fattizzo B; Cavallaro F; Milesi G; Barcellini W
    Am J Hematol; 2019 Sep; 94(9):E237-E239. PubMed ID: 31172568
    [No Abstract]   [Full Text] [Related]  

  • 5. Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia.
    Assi R; Garcia-Manero G; Ravandi F; Borthakur G; Daver NG; Jabbour E; Burger J; Estrov Z; Dinardo CD; Alvarado Y; Hendrickson S; Ferrajoli A; Wierda W; Cortes J; Kantarjian H; Kadia TM
    Cancer; 2018 Nov; 124(21):4192-4201. PubMed ID: 30307606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with antithymocyte globulin and cyclosporin A of a severe aplastic anaemia associated with an eosinophilic fasciitis.
    Bonnotte B; Chauffert B; Caillot D; Martin F; Lorcerie B
    Br J Rheumatol; 1998 Dec; 37(12):1358-9. PubMed ID: 9973169
    [No Abstract]   [Full Text] [Related]  

  • 7. An Eltrombopag Red (Plasma) Alert.
    Al-Samkari H; Goodarzi K
    Acta Haematol; 2021; 144(2):227-228. PubMed ID: 32702690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag.
    Fattizzo B; Kulasekararaj AG; Hill A; Benson-Quarm N; Griffin M; Munir T; Arnold L; Riley K; Ireland R; De Lavallade H; Potter V; Consonni D; Hillmen P; Mufti GJ; Barcellini W; Marsh JCW
    Haematologica; 2019 Nov; 104(11):e494-e496. PubMed ID: 30890599
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose cyclophosphamide in aplastic anaemia.
    Brodsky RA; Jones RJ
    Lancet; 2001 Apr; 357(9262):1128-9. PubMed ID: 11303606
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
    Gupta V; Bhatia B
    Indian J Pediatr; 2009 Sep; 76(9):970-1; author reply 971-2. PubMed ID: 19381516
    [No Abstract]   [Full Text] [Related]  

  • 11. Are eltrombopag plasma and skin hyperpigmentation related? The eyes have it.
    Rodgers GM; Kurtti AL; Gilreath JA
    Am J Hematol; 2019 Mar; 94(3):394-395. PubMed ID: 30033660
    [No Abstract]   [Full Text] [Related]  

  • 12. Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia.
    Takahashi Y; Muramatsu H; Sakata N; Hyakuna N; Hamamoto K; Kobayashi R; Ito E; Yagasaki H; Ohara A; Kikuchi A; Morimoto A; Yabe H; Kudo K; Watanabe K; Ohga S; Kojima S;
    Blood; 2013 Jan; 121(5):862-3. PubMed ID: 23372154
    [No Abstract]   [Full Text] [Related]  

  • 13. Eltrombopag as initial monotherapy for severe aplastic anemia-a case report.
    Rodgers GM; Gilreath JA
    Ann Hematol; 2018 Aug; 97(8):1517-1518. PubMed ID: 29560523
    [No Abstract]   [Full Text] [Related]  

  • 14. Aplastic anemia associated with dyskeratosis congenita treated with antilymphocyte globulin and cyclosporine: a case report.
    Huang HM; Yu WL; Huang YL; Hwang WS; Tsao CJ; Liu HS; Huang GC
    Chin Med J (Engl); 2005 May; 118(9):790-2. PubMed ID: 15899147
    [No Abstract]   [Full Text] [Related]  

  • 15. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
    Song MK; Chung JS; Joo YD; Kim YS; Kim SH; Seol YM; Shin HJ; Choi YJ; Cho GJ
    Eur J Haematol; 2009 Jul; 83(1):72-8. PubMed ID: 19220415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Filippidou M; Avgerinou G; Tsipou H; Tourkantoni N; Katsibardi K; Vlachou A; Roka K; Solomou E; Kattamis A
    Br J Haematol; 2020 Aug; 190(3):e157-e159. PubMed ID: 32529633
    [No Abstract]   [Full Text] [Related]  

  • 17. Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia.
    Fujiwara S; Miyake H; Nosaka K; Yoshida M; Ishihara S; Horikawa K; Yonemura Y; Iyama K; Mitsuya H; Asou N
    Int J Hematol; 2009 Nov; 90(4):471-475. PubMed ID: 19826898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
    Chen C; Fang JP; Huang SL; Zhong FY
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eltrombopag combined with cyclosporine alone for treatment of very severe aplastic anemia: a case report].
    Cheng H; Wang X; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):612. PubMed ID: 32397030
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
    Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
    Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.